Next Article in Journal
Diversification and Fund Performance—An Analysis of Buyout Funds
Previous Article in Journal
What Drives Derivatives: An Indian Perspective
Previous Article in Special Issue
Is One Diagnostic Test for COVID-19 Enough?
Open AccessCommunication

An Economic–Business Approach to Clinical Risk Management

1
Department of Business Sciences, University Giustino Fortunato, 82100 Benevento, Italy
2
School of Management, the University of South Australia, Adelaide 5000, Australia
3
Department of Economics and Finance, Sustainable Real Estate Research Center, Hong Kong Shue Yan University, Hong Kong 999077, China
4
Wolfson College, Oxford University, Oxford OX2 6UD, UK
5
Institute of Biomedical and Environmental Science and Technology, University of Bedfordshire, Luton LU1 3JU, UK
6
School of Life Sciences, Shanxi University, Taiyuan 030006, China
7
Discipline of International Business, University of Sydney, Sydney, NSW 2006, Australia
8
Rattanakosin International College of Creative Entrepreneurship, Rajamangala University of Technology Rattanakosin, Nakhon Pathom 73170, Thailand
9
Department of Computer Science and Engineering, School of Sciences, European University Cyprus, Nicosia 1516, Cyprus
10
CIICESI, ESTG, Politécnico do Porto, 4610-156 Felgueiras, Portugal
11
School of Domestic and International Business, Banking and Finance, Romanian-American University, 012101 Bucharest, Romania
*
Author to whom correspondence should be addressed.
J. Risk Financial Manag. 2020, 13(6), 135; https://doi.org/10.3390/jrfm13060135
Received: 30 April 2020 / Revised: 14 June 2020 / Accepted: 19 June 2020 / Published: 23 June 2020
(This article belongs to the Special Issue COVID-19’s Risk Management and Its Impact on the Economy)
This paper introduces risk factors in the field of healthcare and discusses the clinical risks, identification, risk management methods, and tools as well as the analysis of specific situations. Based on documentary analysis, an efficient and coherent methodological choice of an informative and non-interpretative approach, it relies on “unobtrusive” and “non-reactive” information sources, such that the research results are not influenced by the research process itself. To ensure objective and systematical analysis, our research involved three macro-phases: (a) the first involved a skimming (a superficial examination) of the documents collected; (b) the second reading (a thorough examination) allowed a selection of useful information; (c) the third phase involved classification and evaluation of the collected data. This iterative process combined the elements of content and thematic analysis that categorised the information into different categories which were related to the central issues for research purposes. Finally, from the perspective of safety analysis and risk management, we suggest that comprehensive control and operation should be conducted in a holistic way, including patient safety, cost consumption, and organizational responsibility. An organizational strategy that revolves around a constant and gradual risk management process is an important factor in clinical governance which focuses on the safety of patients, operators, and organizations. View Full-Text
Keywords: risk management; clinical risk; welfare; patient; safety risk management; clinical risk; welfare; patient; safety
Show Figures

Figure 1

MDPI and ACS Style

Comite, U.; Dong, K.; Li, R.Y.M.; Crabbe, M.J.C.; Shao, X.-F.; Yue, X.-G. An Economic–Business Approach to Clinical Risk Management. J. Risk Financial Manag. 2020, 13, 135.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop